Mapping a Killer

Mapping a Killer
Someone dies from tuberculosis every 20 seconds, yet there's still no effective vaccine. Our groundbreaking map of the Mycobacterium tuberculosis gene regulatory network lays the foundation for new treatments. Learn More > >

Unlocking Malaria

Unlocking Malaria
Victims of cerebral malaria often die from malaria-induced blood clots. Seattle BioMed’s Joe Smith, Ph.D., and a global team, pinpointed the lock-and-key mechanism that allows clots to form. Learn more >>


June's issue of Discover features Stefan Kappe discussing work underway to develop malaria vaccines at Seattle BioMed. While the full article is only available to magazine subscribers, you can check out a preview here.

Dr. Ken Stuart is honored to recieve the Alice and C.C. Wang Award in Molecular Parasitology. The award recognizes scientific leaders currently making novel and significant discoveries on the biology of parasitic organisms.     >> More

HIV/AIDS Vaccine Work 
In collaboration with four other organziations, Seattle BioMed announces a $9.8M grant from the NIH to advance neutralizing antibody reserach from preclinical to clinical trials.   More >>

At Seattle BioMed, we are tipping the fight against infectious disease.  We put HIV, tuberculosis and malaria scientists under one roof with systems biology experts to work on our only agenda: to do science that accelerates progress and improves lives. >> Watch our video

 

While great strides have been made, nearly 216 million contract malaria every year. As many as 600,000 lives, mostly children under age 5, are lost annually. World Malaria Day 2014's theme is "Invest in the Future. Defeat Malaria." >>Find out how we are helping to understand this deadly pathogen.

Novel Agents Capable of Killing TB Identified

Researchers in the lab of Professor David Sherman, Ph.D., have developed and screened several compounds with antibacterial properties capable of destroying Mycobacterium tuberculosis (Mtb), the bacterium that causes TB. These compounds, called anti-folates, block the folate pathway, which is responsible for the synthesis of the essential cellular building blocks, without which Mtb cannot survive. The results of this study were published in the June issue of the journal Chemistry and Biology.  More >>

Scientist spotlight: Dan Zak, Ph.D.

With formal training in chemical engineering and a passion for playing the sarod (stringed instrument from India) Scientist Dan Zak brings a unique and valuable skill set to Seattle BioMed. Dan took a moment to answer a few questions; read the interview

News + Events

Seattle BioMed and Yecuris Team Up to Identify Novel Vaccine and Drug Candidates for Malaria
Seattle BioMed and the Yecuris Corporation today announced that they are to begin testing of novel intervention strategies for
Drug Delivery Via Mosquito - Discover Magazine
July 24, 2014

Connect with Us

Stay informed. Sign up for our email newsletter

Find out what the BUZZ is all about.

visit our labs
[ Lab to Life Tour ]